Kontafarma China Holdings (HKSE:01312) Common Stock: HK$11.2 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Kontafarma China Holdings Common Stock?

Kontafarma China Holdings HKSE:01312 +3.03% Common Stock is HK$11.2 Mil as of Jun. 2026. The stock has 6 warning signs investors should review.

Kontafarma China Holdings's quarterly common stock increased from Jun. 2025 (HK$11.2 Mil) to Dec. 2025 (HK$11.2 Mil) but then declined from Dec. 2025 (HK$11.2 Mil) to Jun. 2026 (HK$11.2 Mil).

Kontafarma China Holdings's annual common stock declined from Dec. 2023 (HK$11.2 Mil) to Dec. 2024 (HK$11.2 Mil) but then increased from Dec. 2024 (HK$11.2 Mil) to Dec. 2025 (HK$11.2 Mil).

Kontafarma China Holdings Common Stock Historical Data

* Premium members only.

The historical data trend for Kontafarma China Holdings's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kontafarma China Holdings Common Stock Chart

Kontafarma China Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.18 11.18 11.18 11.18 11.18

Kontafarma China Holdings Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.18 11.18 11.18 11.18 11.18

Kontafarma China Holdings Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of HK$11.2 Mil mean?
Kontafarma China Holdings (HKSE:01312) has a Common Stock of HK$11.2 Mil as of Jun. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Kontafarma China Holdings and its competitors.
Is Kontafarma China Holdings' Common Stock too high?
Kontafarma China Holdings' current Common Stock is HK$11.2 Mil.
How does Kontafarma China Holdings' Common Stock compare to ZTS?
Kontafarma China Holdings' Common Stock of HK$11.2 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Kontafarma China Holdings and its competitors. Kontafarma China Holdings's current Common Stock is HK$11.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kontafarma China Holdings stock overvalued right now?
Based on GuruFocus' analysis, Kontafarma China Holdings (HKSE:01312) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$0.03, compared to a current price of HK$0.03 — trading 13.3% above its estimated fair value. The current Common Stock is HK$11.2 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Kontafarma China Holdings (HKSE:01312), the current Common Stock is HK$11.2 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kontafarma China Holdings Business Description

Address 30 Harbour Road, Room 12A15-12A20, 12A Floor, Sun Hung Kai Centre, Wanchai, Hong Kong, HKG
Kontafarma China Holdings Ltd and its subsidiaries are principally engaged in the pharmaceutical and fitness business. The Group manufactures and sells prescription drugs, including chemical drugs, traditional Chinese medicine prescriptions, active pharmaceutical ingredients, and API intermediates in China, and operates fitness centres, provides fitness and health consultation services, and operates a franchise business for royalty fee income. Its segments are the pharmaceutical business, which generates maximum revenue, and the fitness business. The Group operates in Mainland China, Singapore, Taiwan, and other regions, with maximum revenue from Mainland China.